DiaSorin's LIAISON® SARS-CoV-2 Diagnostic Solutions | DiaSorin
DiaSorin S.p.A. : Shareholders Board Members Managers and Company Profile | IT0003492391 | MarketScreener
DiaSorin to buy Luminex for $1.8B - MassDevice
Italian test maker DiaSorin puts down $1.8B for Luminex in diagnostics tie-up | Fierce Biotech
DiaSorin S.p.A. (DSRL.F) Company Information - Simply Wall St
REPORT ON THE REMUNERATION POLICY FOR THE YEAR 2022 AND REMUNERATION PAID IN THE YEAR 2021 OF DIASORIN S.p.A.
DiaSorin: Overvalued Italian Healthcare Company (OTCMKTS:DSRLF) | Seeking Alpha
Annual Financial Report
Annual Financial Report
Diasorin heads to the US with $1.8bn Luminex deal | Evaluate
Untitled
DiaSorin | LinkedIn
COVID-19 | Updates | DiaSorin
DiaSorin : Incorporating medium-term hiccups; but re-rating potential remains intact
DiaSorin | LinkedIn
Annual Financial Report
DiaSorin S.p.A. (DIA) Company Information - Simply Wall St
Borsa: Milano recupera (-0,5%) con Mps, male Cnh e Diasorin - Notizie - Ansa.it
DiaSorin
DiaSorin Italia S.p.A. | DiaSorin
DiaSorin Inc. | LinkedIn
Kinetics and seroprevalence of SARS-CoV-2 antibodies: a comparison of 3 different assays | Scientific Reports
DiaSorin Molecular LLC | LinkedIn
Homepage - DiaSorin Molecular
DiaSorin | Saluggia
DiaSorin Spa Italy - DiaSorin Molecular
DiaSorin - The Diagnostic Specialist
DiaSorin concludes acquisition of Luminex for $1.8bn
Shares in Diasorin surge ahead of coronavirus diagnostic test launch
DiaSorin | Saluggia
/cloudfront-us-east-2.images.arcpublishing.com/reuters/34L6IFUZ2JLLDHCVNW34Y664HE.jpg "Italy's DiaSorin sees 60% plunge in COVID-19 revenue next year | Reuters")
Italy's DiaSorin sees 60% plunge in COVID-19 revenue next year | Reuters
ASSEMBLEA DEGLI AZIONISTI
LIAISON® XL | DiaSorin
DiaSorin Molecular LLC | LinkedIn
Annual Financial Report
COVID-19 | Updates | DiaSorin
proudtobeDiaSorin | DiaSorin
DiaSorin Molecular LLC | LinkedIn
DiaSorin | LinkedIn
DiaSorin - The Diagnostic Specialist
Milan: DiaSorin in the red - Borsa Italiana
Italian biotech company DiaSorin says its Covid-19 tests can detect omicron variant - YouTube
Results | DiaSorin
DiaSorin - The Diagnostic Specialist
Borsa: Milano frena ancora (-1,1%), pesano Diasorin e Stellantis - Notizie - Ansa.it
DiaSorin Inc. | LinkedIn
Diasorin, il titolo vola in borsa dopo i conti del primo semestre: utili e ricavi in calo ma sopra le attese - MilanoFinanza News
DiaSorin - The Diagnostic Specialist
Covid-19 Tests in America: DiaSorin Gets FDA Emergency-Use Rights - Bloomberg
Italy's DiaSorin sees 60% plunge in COVID-19 revenue next year | Reuters
DiaSorin Molecular LLC | LinkedIn
